Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07368972 · ClinicalTrials.gov registry record · Phase 2

Study of DISC-0974-201 in Participants With IBD and Anemia

A Phase 2 study of Anemia and Inflammatory Bowel Disease (IBD), sponsored by Disc Medicine.

Recruiting
Registry status
Phase 2
Development phase
21
Enrollment target
5
Study locations

NCT07368972 is a Phase 2 study of Anemia and Inflammatory Bowel Disease (IBD) that is actively recruiting participants, run by Disc Medicine. The registered enrollment target is 21 participants, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (95% lower). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07368972, a Phase 2 study of Anemia and Inflammatory Bowel Disease (IBD), is actively recruiting participants, sponsored by Disc Medicine.

RECRUITING
Registry status
Phase 2
Development phase
21 participants
Enrollment target
5
Study locations

Study Summary

This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.

Conditions Studied

Anemia Inflammatory Bowel Disease (IBD) Inflammatory Bowel Disease (IBD); Anemia

Interventions

  • DRUG Placebo
  • DRUG DISC-0974

Study Locations (5)

Florida

  • Clinical Research of Osceola, LLC - Kissimmee
  • Anchor Medical Research, LLC - Miami
  • Guardian Angel Research, Inc - Tampa

Arizona

  • One of a Kind Clinical Research Center, LLC - Scottsdale

Texas

  • One of a Kind Clinical Research Center, LLC - Kingwood

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2026-02-20
Est. Completion 2027-03
Phase Phase 2

Sponsor

Disc Medicine

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07368972

The ClinicalTrials.gov registry entry for NCT07368972 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (95% lower). The listed sponsor is Disc Medicine, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anemia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07368972 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Florida, Arizona, Texas.

Frequently Asked Questions

What is clinical trial NCT07368972 about?

NCT07368972 is a clinical study titled "Study of DISC-0974-201 in Participants With IBD and Anemia". This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.

What is the current status of trial NCT07368972?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2026-02-20. Estimated completion is 2027-03.

What conditions does trial NCT07368972 study?

This clinical trial studies the following conditions: Anemia, Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia.

What interventions are being tested in trial NCT07368972?

The interventions under investigation include: Placebo (DRUG), DISC-0974 (DRUG).

Who is sponsoring clinical trial NCT07368972?

This trial is sponsored by Disc Medicine, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07368972 being conducted?

This trial has 5 study locations across Arizona, Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Anemia

All registered trials for this condition

Inflammatory Bowel Disease (IBD)

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.